Roitman Pablo D, Farfalli Germán L, Ayerza Miguel A, Múscolo D Luis, Milano Federico E, Aponte-Tinao Luis A
Pathology Department, Italian Hospital of Buenos Aires, Juan D. Perón 4190, 1199, Buenos Aires, Argentina.
Institute of Orthopedics "Carlos E. Ottolenghi", Italian Hospital of Buenos Aires, Buenos Aires, Argentina.
Clin Orthop Relat Res. 2017 Mar;475(3):808-814. doi: 10.1007/s11999-016-4738-y.
Central chondrosarcoma of bone is graded on a scale of 1 to 3 according to histological criteria. Clinically, these tumors can be divided into low-grade (Grade 1) and high-grade (Grade 2, Grade 3, and dedifferentiated) chondrosarcomas. Although en bloc resection has been the most widely used treatment, it has become generally accepted that in selected patients with low-grade chondrosarcomas of long bones, curettage is safe and effective. This approach requires an accurate preoperative estimation of grade to avoid under- or overtreatment, but prior reports have indicated that both imaging and biopsy do not always give an accurate prediction of grade.
QUESTIONS/PURPOSES: (1) What is the concordance of image-guided needle preoperative biopsy and postoperative grading in central (intramedullary) chondrosarcomas of long bones, and how does this compare with the concordance of image-guided needle preoperative biopsy and postoperative grading in central pelvic chondrosarcomas? (2) What is the concordance of preoperative image-guided needle biopsy and postoperative findings in differentiating low-grade from high-grade central chondrosarcomas of long bones, and how does this compare with the concordance in central pelvic chondrosarcomas?
Between 1997 and 2014, in our institution, we treated 126 patients for central chondrosarcomas located in long bones and the pelvis. Of these 126 cases, 41 were located in the pelvis and the remaining 85 cases were located in long bones. This study considers 39 (95%) and 40 (47%) of them, respectively. We included all cases in which histological information was complete regarding preoperative and postoperative tumor grading. We excluded all cases with incomplete data sets or nondiagnostic preoperative biopsies. To evaluate the needle biopsy accuracy, we compared the histological tumor grade, obtained from the preoperative biopsy, with the final histological grade obtained from the postoperative surgical specimen. The weighted and nonweighted kappa statistics were used to evaluate the agreement.
Concordance between the preoperative biopsy and the final pathological analysis in terms of histological grade was much higher in long-bone chondrosarcoma than in pelvic chondrosarcoma (83% [33 of 40] versus 36% [14 of 39]; odds ratio, 8, 48). Likewise, the weighted kappa coefficients were higher in long-bone chondrosarcoma than in pelvic chondrosarcoma for the determination of histological grade (0.63; 95% confidence interval [CI], 0.34-0.91 versus 0.12; -0.32 to 0.57; p < 0.001). When categorizing the lesions as low grade or high grade, concordance between the preoperative biopsy and the final pathological analysis was much higher in long-bone chondrosarcoma than in pelvic chondrosarcoma (90% [36 of 40] versus 67% [26 of 39]; odds ratio, 4, 5). Likewise, the weighted kappa coefficients were higher in long-bone chondrosarcoma than in pelvic chondrosarcoma (0.73; 95% CI, 0.51-0.94 versus 0.26; 0.04-0.48; p < 0.001).
Image-guided needle biopsy, when performed by a specialist radiologist and evaluated by an experienced bone pathologist, is a useful tool in determining the histological grade of long-bone chondrosarcomas allowing identification of true low-grade tumors. The histological grade should be correlated with imaging and the clinical presentation, but under these circumstances, experienced tumor surgeons may use this information in planning surgical treatment. The same appears not to be true for pelvic lesions, in which histological grade established by needle biopsy should be interpreted with caution.
Level III, diagnostic study.
骨中央型软骨肉瘤根据组织学标准分为1至3级。临床上,这些肿瘤可分为低级别(1级)和高级别(2级、3级及去分化型)软骨肉瘤。尽管整块切除一直是最广泛应用的治疗方法,但目前普遍认为,对于部分长骨低级别软骨肉瘤患者,刮除术是安全有效的。这种方法需要对分级进行准确的术前评估,以避免治疗不足或过度治疗,但既往报道表明,影像学检查和活检并不总能准确预测分级。
问题/目的:(1)长骨中央型(髓内)软骨肉瘤的影像引导下针吸术前活检与术后分级的一致性如何,与骨盆中央型软骨肉瘤的影像引导下针吸术前活检与术后分级的一致性相比如何?(2)长骨中央型软骨肉瘤术前影像引导下针吸活检与术后结果在区分低级别与高级别方面的一致性如何,与骨盆中央型软骨肉瘤的一致性相比如何?
1997年至2014年,在我们机构,我们治疗了126例位于长骨和骨盆的中央型软骨肉瘤患者。在这126例病例中,41例位于骨盆,其余85例位于长骨。本研究分别纳入其中的39例(95%)和40例(47%)。我们纳入了所有术前和术后肿瘤分级组织学信息完整的病例。我们排除了所有数据集不完整或术前活检未明确诊断的病例。为评估针吸活检的准确性,我们将术前活检获得的组织学肿瘤分级与术后手术标本获得的最终组织学分级进行比较。采用加权和非加权kappa统计量评估一致性。
长骨软骨肉瘤术前活检与最终病理分析在组织学分级方面的一致性远高于骨盆软骨肉瘤(83%[40例中的33例]对36%[39例中的14例];优势比为8.48)。同样,在确定组织学分级方面,长骨软骨肉瘤的加权kappa系数高于骨盆软骨肉瘤(0.63;95%置信区间[CI],0.34 - 0.91对0.12; - 0.32至0.57;p < 0.001)。当将病变分为低级别或高级别时,长骨软骨肉瘤术前活检与最终病理分析的一致性远高于骨盆软骨肉瘤(90%[40例中的36例]对67%[39例中的26例];优势比为4.5)。同样,长骨软骨肉瘤的加权kappa系数高于骨盆软骨肉瘤(0.73;95%CI,0.51 - 0.94对0.26;0.04 - 0.48;p < 0.001)。
由专业放射科医生进行并由经验丰富的骨病理学家评估的影像引导下针吸活检,是确定长骨软骨肉瘤组织学分级的有用工具,有助于识别真正的低级别肿瘤。组织学分级应与影像学检查和临床表现相关,但在这种情况下,经验丰富的肿瘤外科医生可在制定手术治疗方案时利用这些信息。对于骨盆病变,情况似乎并非如此,针吸活检确定的组织学分级应谨慎解读。
III级,诊断性研究。